Suppr超能文献

仅行肠系膜上动脉血运重建术治疗肠缺血。

Revascularization of the superior mesenteric artery alone for treatment of intestinal ischemia.

作者信息

Foley M I, Moneta G L, Abou-Zamzam A M, Edwards J M, Taylor L M, Yeager R A, Porter J M

机构信息

Division of Vascular Surgery, Oregon Health Sciences University, Portland, OR 97201-3098, USA.

出版信息

J Vasc Surg. 2000 Jul;32(1):37-47. doi: 10.1067/mva.2000.107314.

Abstract

OBJECTIVE

Complete revascularization is recommended by many authors for treatment of intestinal ischemia. The observation that postprandial intestinal hyperemia is limited to the superior mesenteric artery (SMA) has suggested to us that SMA revascularization alone should be adequate treatment. We preferentially manage intestinal ischemia with a single bypass graft to the SMA and herein update our results using this approach.

METHODS

Patients were identified from a prospectively established vascular surgical registry. Each patient was assessed for acute versus chronic intestinal ischemia, preoperative angiographic findings, operation used, perioperative morbidity and mortality, late symptomatic relief, cause of death, and life table-determined survival and graft patency. Graft patency was determined by follow-up angiography or duplex scanning.

RESULTS

Fifty bypass grafts to the SMA alone were performed in 49 patients (31 women, 18 men; mean age, 62 years) for treatment of intestinal ischemia. In all patients additional splanchnic arteries were available for bypass grafting. Operative indications were acute symptoms in 21 patients, 14 of whom had bowel infarction; chronic symptoms in 26 patients; and prophylaxis in conjunction with infrarenal aortic surgery in 3 patients. Thirty-two grafts originated from the aorta or an iliac artery, and 18 originated from an aortic graft. There were 40 prosthetic and 10 autogenous conduits. Perioperative mortality was 3% in patients with chronic symptoms and 12% overall. All survivors were symptomatically improved. Mean follow-up was 44 months. Nine-year assisted primary graft patency was 79%, and 5-year patient survival was 61%. Two late deaths occurred in patients with recurrent intestinal ischemia resulting from graft occlusions.

CONCLUSIONS

Bypass grafting to the SMA alone appears to be both an effective and durable procedure for treatment of intestinal ischemia. Our results appear equal to those reported for "complete" revascularization for intestinal ischemia. When the SMA is a suitable recipient vessel, multiple bypass grafts to other splanchnic vessels are unnecessary in the treatment of intestinal ischemia.

摘要

目的

许多作者推荐对肠缺血进行完全血运重建治疗。餐后肠充血仅限于肠系膜上动脉(SMA)这一观察结果提示我们,仅对SMA进行血运重建应是充分的治疗方法。我们优先采用单根移植血管旁路移植至SMA来处理肠缺血,并在此更新我们使用该方法的结果。

方法

从前瞻性建立的血管外科登记处识别患者。评估每位患者的急性与慢性肠缺血情况、术前血管造影结果、所采用的手术方式、围手术期发病率和死亡率、晚期症状缓解情况、死亡原因以及生命表确定的生存率和移植血管通畅率。移植血管通畅率通过随访血管造影或双功超声扫描确定。

结果

49例患者(31例女性,18例男性;平均年龄62岁)仅接受了50次SMA旁路移植术以治疗肠缺血。所有患者均有其他内脏动脉可用于旁路移植。手术指征为21例患者有急性症状,其中14例有肠梗死;26例患者有慢性症状;3例患者在肾下腹主动脉手术时进行预防性手术。32根移植血管起源于主动脉或髂动脉,18根起源于主动脉移植血管。有40根人工血管和10根自体血管。慢性症状患者围手术期死亡率为3%,总体为12%。所有幸存者症状均有改善。平均随访44个月。9年辅助原发性移植血管通畅率为79%,5年患者生存率为61%。2例晚期死亡发生在因移植血管闭塞导致复发性肠缺血的患者中。

结论

仅对SMA进行旁路移植术似乎是治疗肠缺血的一种有效且持久的方法。我们的结果似乎与报道的肠缺血“完全”血运重建的结果相当。当SMA是合适的受体血管时,在肠缺血治疗中无需对其他内脏血管进行多次旁路移植。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验